Drug Shortage Report for MAR-RANITIDINE
Report ID | 141818 |
Drug Identification Number | 02443708 |
Brand name | MAR-RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 TABLET |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-07-04 |
Estimated end date | 2021-10-30 |
Actual end date | 2022-01-15 |
Shortage status | Resolved |
Updated date | 2022-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-07-20 | French | Compare |
v3 | 2022-07-20 | English | Compare |
v2 | 2021-07-05 | French | Compare |
v1 | 2021-07-05 | English | Compare |
Showing 1 to 4 of 4